TRIB1 confers resistance to radiation treatment in GBM by inhibiting p53 function

被引：0
|
作者：
Singh, K. [1 ]
Han, C. [1 ]
Fleming, J. [1 ]
Kumar, A. [1 ]
Showalter, C. [1 ]
Tong, Z. [1 ]
Becker, V. [1 ]
Meng, X. [1 ]
Becker, A. [1 ]
Manring, H. [1 ]
Haque, S. J. [1 ]
Chakravarti, A. [1 ]
机构：
[1] Ohio State Univ, Ctr Comprehens Canc, Radiat Oncol, Columbus, OH 43210 USA
来源：
RADIOTHERAPY AND ONCOLOGY | 2023年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD-0818
引用
收藏
页码：S689 / S689
页数：1
相关论文
共 50 条
  • [1] TRIB1 confers therapeutic resistance in GBM cells by activating the ERK and Akt pathways
    Singh, Karnika
    Han, Chunhua
    Fleming, Jessica L.
    Becker, Aline P.
    McElroy, Joseph
    Cui, Tiantian
    Johnson, Benjamin
    Kumar, Ashok
    Sebastian, Ebin
    Showalter, Christian A.
    Schrock, Morgan S.
    Summers, Matthew K.
    Becker, Valesio
    Tong, Zhen-yue
    Meng, Xiaomei
    Manring, Heather R.
    Venere, Monica
    Bell, Erica H.
    Robe, Pierre A.
    Grosu, A. L.
    Haque, S. Jaharul
    Chakravarti, Arnab
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [2] TRIB1 confers therapeutic resistance in GBM cells by activating the ERK and Akt pathways
    Karnika Singh
    Chunhua Han
    Jessica L. Fleming
    Aline P. Becker
    Joseph McElroy
    Tiantian Cui
    Benjamin Johnson
    Ashok Kumar
    Ebin Sebastian
    Christian A. Showalter
    Morgan S. Schrock
    Matthew K. Summers
    Valesio Becker
    Zhen-yue Tong
    Xiaomei Meng
    Heather R. Manring
    Monica Venere
    Erica H. Bell
    Pierre A. Robe
    A. L. Grosu
    S. Jaharul Haque
    Arnab Chakravarti
    [J]. Scientific Reports, 13
  • [3] TRIBBLES1 (TRIB1) Pseudokinase Induces Treatment Resistance in GBM by Promoting Survival of Tumor Cells through the Akt Pathway
    Singh, K.
    Han, C.
    Fleming, J. L.
    McElroy, J.
    Bell, E. H.
    Manring, H.
    Haque, S. J.
    Chakravarti, A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E79 - E80
  • [4] TRIBBLES-1 (TRIB1) INCREASES TUMOR FORMATION IN AN ORTHOTOPIC MOUSE MODELS BY PROMOTING SURVIVAL OF GBM CELLS AND TREATMENT RESISTANCE
    Singh, Karnika
    Han, Chunhua
    Fleming, Jessica
    McElroy, Joseph
    Kumar, Ashok
    Sebastian, Ebin
    Bell, Erica
    Robe, Pierre
    Haque, Jahar
    Chakravarti, Arnab
    [J]. NEURO-ONCOLOGY, 2021, 23 : 39 - 39
  • [5] THE DEATH DOMAIN KINASE RIP1 INHIBITS P53 INDUCTION AND CONFERS A WORSE PROGNOSIS IN GBM
    Park, Seongmi
    Hatanpaa, Kimmo
    Xie, Yang
    Mickey, Bruce
    Ramnarain, Deepti
    Madden, Christopher
    Habib, Amyn
    [J]. NEURO-ONCOLOGY, 2008, 10 (05) : 767 - 767
  • [6] p53 mutations and loss of p53 function confer multidrug resistance in neuroblastoma
    Keshelava, N
    Zuo, JJ
    Waidyaratne, NS
    Triche, TJ
    Reynolds, CP
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 2000, 35 (06): : 563 - 568
  • [7] Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines'
    Keshelava, N
    Zuo, JJ
    Chen, P
    Waidyaratne, SN
    Luna, MC
    Gomer, CJ
    Triche, TJ
    Reynolds, CP
    [J]. CANCER RESEARCH, 2001, 61 (16) : 6185 - 6193
  • [8] Modulation of acquired resistance to cetuximab and radiation by p53
    Huang, Shyhmin
    Li, Chunrong
    Wheeler, Deric
    Harari, Paul
    [J]. CANCER RESEARCH, 2009, 69
  • [9] Modulating Radiation Resistance by Inhibiting Ribonucleotide Reductase in Cancers with Virally or Mutationally Silenced p53 Protein
    Kunos, Charles A.
    Chiu, Song-mao
    Pink, John
    Kinsella, Timothy J.
    [J]. RADIATION RESEARCH, 2009, 172 (06) : 666 - 676
  • [10] FBXW7 Confers Radiation Survival by Targeting p53 for Degradation
    Cui, Danrui
    Xiong, Xiufang
    Shu, Jianfeng
    Dai, Xiaoqing
    Sun, Yi
    Zhao, Yongchao
    [J]. CELL REPORTS, 2020, 30 (02): : 497 - +
12345